Mirvetuximab soravtansine Antibody
Selected Variant
GTR18398568-01
Size: 1 mg
Mirvetuximab soravtansine (IMGN853) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) for cancer research. It delivers a cytotoxic payload to inhibit proliferation and has demonstrated activity in preclinical models of ovarian cancer, including studies involving drug-resistant cell lines and xenograft models.
Product Specifications
Product Name Alternative
Mirvetuximab soravtansine, IMGN 853, IMGN853, IMGN-853, FRα, TAK-853
Target
Antifolate
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
9.72 mg/mL
Purity
90.53% (May vary between batches)
Molecular Weight
145.76 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400897-500 1x 500 µL
Mucin 5AC (MUC5AC) (CLH2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741176-500 1x 500 µL
EMI1 (EMI1/1176), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
M02702-1-PE 100 µg/Vial
Anti-RbAp48 RBBP4 Antibody Picoband® (monoclonal, 9F3), PE Conjugate
Sign In for Pricing
View Details 
BNC742838-500 1x 500 µL
Desmoglein-3 (Squamous Cell Marker) (DSG3/2838), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details